The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population
Open accessAbstract
Background: Earlier tissue plasminogen activator treatment improves ischemic stroke outcome, but aspects of the time-benefit relationship still not well delineated are: (1) the degree of additional benefit accrued with treatment in the first 60 minutes after onset, and (2) the shape of the time-benefit curve through 4.5 hours. Methods: We analyzed patients who had acute ischemic stroke treated with intravenous tissue plasminogen activator within 4.5 hours of onset from the Get With The Guidelines-Stroke US national program. Onset-to-treatment time was analyzed as a continuous, potentially nonlinear variable and as a categorical variable comparing patients treated within 60 minutes of onset with later epochs. Results: Among 65 384 tissue plasminogen activator–treated patients, the median onset-to-treatment time was 141 minutes (interquartile range, 110–173) and 878 patients (1.3%) were treated within the first 60 minutes. Treatment within 60 minutes, compared with treatment within 61 to 270 minutes, was associated with increased odds of discharge to home (adjusted odds ratio, 1.25; 95% confidence interval, 1.07–1.45), independent ambulation at discharge (adjusted odds ratio, 1.22; 95% confidence interval, 1.03–1.45), and freedom from disability (modified Rankin Scale 0–1) at discharge (adjusted odds ratio, 1.72; 95% confidence interval, 1.21–2.46), without increased hemorrhagic complications or in-hospital mortality. The pace of decline in benefit of tissue plasminogen activator from onset-to-treatment times of 20 through 270 minutes was mildly nonlinear for discharge to home, with more rapid benefit loss in the first 170 minutes than later, and linear for independent ambulation and in-hospital mortality. Conclusions: Thrombolysis started within the first 60 minutes after onset is associated with best outcomes for patients with acute ischemic stroke, and benefit declined more rapidly early after onset for the ability to be discharged home. These findings support intensive efforts to organize stroke systems of care to improve the timeliness of thrombolytic therapy in acute ischemic stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Emberson, J., Lees, K. R., Lyden, P., Blackwell, L., Albers, G., Bluhmki, E., Brott, T., Cohen, G., Davis, S., Donnan, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60584-5 · Cited by 2,737
Self-citation
Cited by
Endovascular Treatment of Acute Ischemic Stroke
Jahan, R., & Saver, J. L. (2022) · Stroke · doi:10.1016/b978-0-323-69424-7.00067-3 · Cited by 396
Self-citationProspective, Multicenter, Controlled Trial of Mobile Stroke Units
Grotta, J. C., Yamal, J.-M., Parker, S. A., Rajan, S. S., Gonzales, N. R., Jones, W. J., Alexandrov, A. W., Navi, B. B., Nour, M., Spokoyny, I., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103879 · Cited by 264
Self-citationNih, L. R., Sideris, E., Carmichael, S. T., & Segura, T. (2017) · Advanced Materials · doi:10.1002/adma.201606471 · Cited by 262
Ebinger, M., Siegerink, B., Kunz, A., Wendt, M., Weber, J. E., Schwabauer, E., Geisler, F., Freitag, E., Lange, J., Behrens, J., et al. (2021) · JAMA · doi:10.1001/jama.2020.26345 · Cited by 256
Focusing on claudin-5: A promising candidate in the regulation of BBB to treat ischemic stroke
Lv, J., Hu, W., Yang, Z., Li, T., Jiang, S., Ma, Z., Chen, F., & Yang, Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.12.001 · Cited by 148
Metadata
- Authors
- Kim, J.-T., Fonarow, G. C., Smith, E. E., Reeves, M. J., Navalkele, D. D., Grotta, J. C., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Schwamm, L. H., & Saver, J. L.
- Venue
- Circulation
- Published
- 2017-01-10
- Volume
- 135
- Issue
- 2
- Pages
- 128-139
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2548945162
- Cited by
- 184
- References
- 2
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population. https://app.cochat.ai/papers/10.1161/circulationaha.116.023336
- The paper
- Kim, J.-T., Fonarow, G. C., Smith, E. E., Reeves, M. J., Navalkele, D. D., Grotta, J. C., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Schwamm, L. H., & Saver, J. L. (2017). Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population. Circulation. https://doi.org/10.1161/circulationaha.116.023336
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.